Delivery Order SPE2DB24D3015-SPE2DB24FFXHU
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets, with a ceiling value of $14,549.08 and a completion date of May 17, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract, valued at $2,801.40, is a firm fixed-price Delivery Order with a performance period through August 15, 2024. It is not set-aside for any socioeconomic program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages, with a total ceiling value of $8,607.73 and a completion date of November 14, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has a firm fixed price of $1,539.86 and a completion date of February 20, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg ondansetron orally disintegrating tablets. The contract has a ceiling value of $3,482.29 and a performance period that runs through January 22, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,135,765 units of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has a ceiling value of $3,182.20 and runs through February 4, 2025. It is a firm-fixed-price delivery order contract. The contract is not designated as a set-aside....
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Ondansetron orally disintegrating tablets. The contract has a ceiling value of $3,222.53 and an ultimate completion date of August 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999, which AmerisourceBergen holds with the DLA Troop Support Medical to provide a wide range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in quantities of 30 tablets per package. The contract has a firm fixed price of $4,947.60 and a completion date of March 13, 2025. This appears to be an open competition contract, as no set-aside designation is mentioned....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of 4 mg Ondansetron orally disintegrating tablets in 30-count packages. The contract has a ceiling value of $8,361.38 and a period of performance through March 18, 2024. It is a firm fixed price contract with no set-aside designation. AmerisourceBergen Drug Corp has received numerous previous contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in quantities of 30 per package. The award has a ceiling value of $20,590.05 and runs from March 2025 to March 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in...